Bristol (BMY) Position Has Raised by Argent Capital Management Llc

Lloyd Doyle
October 11, 2017

Taconic Capital Advisors Lp sold 50,000 shares as Bristol Myers Squibb Co (BMY)'s stock declined 1.04%. The Hgk Asset Management Inc holds 319,315 shares with $17.79 million value, up from 308,825 last quarter. Argent Capital Management Llc bought 211,100 shares as the company's stock declined 1.04% while stock markets rallied. About 400 shares traded. LLC lifted its position in shares of Bristol-Myers Squibb Company (NYSE:BMY) by 20.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. It has underperformed by 39.89% the S&P500. (DHI) stake by 4.55% reported in 2017Q2 SEC filing. (DHI)'s stock rose 10.82%. Following the completion of the sale, the senior vice president now owns 46,297 shares of the company's stock, valued at $2,777,820. Bristol now has $105.78B valuation. The stock increased 0.12% or $0.05 during the last trading session, reaching $41.28. About 1.73 million shares traded. About shares traded. Express Scripts Holding Company (NASDAQ:ESRX) has declined 16.92% since October 11, 2016 and is downtrending. It has underperformed by 7.38% the S&P500.

Paradigm Asset Management Co Llc decreased Mastec Inc (NYSE:MTZ) stake by 1,300 shares to 1,300 valued at $58.70M in 2017Q2. American National Bank now owns 2,144 shares of the biopharmaceutical company's stock valued at $119,000 after buying an additional 225 shares during the last quarter. Apache Corp. Common (NYSE:APA) was reduced too. It increased, as 14 investors sold EDR shares while 61 reduced holdings. L & S Advisors Incorporated reported 6,140 shares stake. Through this figure traders can analyze that BMY show whether or not a stock now most active and standing in buying side or sell side. Airain Ltd owns 67,781 shares. Guyasuta Invest Advsrs reported 0.03% of its portfolio in Occidental Petroleum Corporation (NYSE:OXY). (NYSE:EDR). Hsbc Hldgs Public Limited Co invested in 0% or 5,639 shares. Tcw Group has 0.02% invested in KT Corp (ADR) (NYSE:KT). Tower Rech Ltd Liability Company (Trc) holds 0.03% or 5,205 shares. Nomura Holdings holds 0% of its portfolio in Paylocity Holding Corp (NASDAQ:PCTY) for 4,602 shares. Signature Fin Management owns 8,327 shares or 0.15% of their U.S. portfolio. Apg Asset Management Nv owns 653,637 shares. Quantum Capital Mngmt reported 0.21% of its portfolio in Occidental Petroleum Corporation (NYSE:OXY). Planning has 27,205 shares for 0.12% of their portfolio. Oregon-based Ferguson Wellman Mngmt has invested 0.29% in KT Corp (ADR) (NYSE:KT).

Among 8 analysts covering 21st Century Fox (FRA:NXW2), 6 have Buy rating, 1 Sell and 1 Hold. Therefore 71% are positive. ProMetic Life Sciences Inc. had 37 analyst reports since August 10, 2015 according to SRatingsIntel. Jefferies maintained the shares of BMY in report on Thursday, July 14 with "Hold" rating. Also, SVP Joseph C. Caldarella sold 9,340 shares of the stock in a transaction dated Wednesday, September 6th. The firm has "Buy" rating given on Wednesday, December 2 by Guggenheim.

Analysts are also projecting an Average Revenue Estimate for Bristol-Myers Squibb Company as $5.17 Million in the Current Quarter. During the same period in the prior year, the business earned $0.69 earnings per share. BMY's profit will be $1.23B for 21.69 P/E if the $0.75 EPS becomes a reality.

Analysts expect Bristol-Myers Squibb Co (NYSE:BMY) to report $0.75 EPS on October, 26 before the open.They anticipate $0.02 EPS change or 2.60% from last quarter's $0.77 EPS. Jefferies maintained Bristol-Myers Squibb Co (NYSE:BMY) on Monday, July 17 with "Buy" rating. Therefore 32% are positive.


Bristol-Myers Squibb Company on 6/29/2017 reported its EPS as $0.77 with the analysts projecting the EPS of the stock as $0.65. Beacon Financial Group raised its position in shares of Bristol-Myers Squibb by 1.6% in the 3rd quarter. Piper Jaffray has "Hold" rating and $6000 target. Bristol-Myers Squibb Company has $80 highest and $45 lowest target. The firm has "Buy" rating given on Friday, September 8 by Northland Capital. On Friday, September 15 the stock rating was maintained by Jefferies with "Buy". Barclays Capital maintained it with "Underweight" rating and $38 target in Friday, August 4 report. Gear Up for Round 2 of the Kidney ..." published on September 14, 2017 as well as Investorplace.com's news article titled: "Buy Bristol-Myers Squibb Co (BMY) Stock With No Fear" with publication date: "September 18, 2017.

01/24/2017 - Bristol-Myers Squibb Company had its "equal-weight" rating reiterated by analysts at Barclays. The rating was maintained by Credit Suisse on Monday, May 9 with "Outperform". BMO Capital Markets reissued a "sell" rating and issued a $49.00 price objective on shares of Bristol-Myers Squibb in a research note on Monday, September 4th.

Investors sentiment decreased to 1.04 in Q2 2017. Its down 0.03, from 0.98 in 2017Q1. It dropped, as 78 investors sold BMY shares while 520 reduced holdings. Crossvault Cap Mngmt Ltd Co holds 122,489 shares. Town & Country Savings Bank & Tru Dba First Bankers Tru holds 85,270 shares. Proficio Capital Partners LLC grew its stake in shares of Bristol-Myers Squibb by 29.6% during the first quarter. 7,774 were reported by Diversified Trust. Ontario Teachers Pension Plan Board, Ontario - Canada-based fund reported 51,697 shares. An ROI of 19.80% for Bristol-Myers Squibb Company evaluates and compares the efficiency of the various numbers of investments relative to the cost of investments. Notis, Alabama-based fund reported 15,161 shares.

11/07/2016 - Bristol-Myers Squibb Company had its "buy" rating reiterated by analysts at Citigroup.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER